Literature DB >> 7061417

Enhanced macrophage uptake of synthetically glycosylated human placental beta-glucocerebrosidase.

T W Doebber, M S Wu, R L Bugianesi, M M Ponpipom, F S Furbish, J A Barranger, R O Brady, T Y Shen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7061417

Source DB:  PubMed          Journal:  J Biol Chem        ISSN： 0021-9258            Impact factor:   5.157


× No keyword cloud information.
  20 in total

1.  Cerebroside-beta-glucosidase encapsulation in liposomes for Gaucher's disease treatment revisited.

Authors:  V Korablyov; A Zimran; Y Barenholz
Journal:  Pharm Res       Date:  1999-03       Impact factor: 4.200

2.  Alglucerase for Gaucher's disease: dose, costs and benefits.

Authors:  E Beutler; A M Garber
Journal:  Pharmacoeconomics       Date:  1994-06       Impact factor: 4.981

3.  Enzyme replacement and gene therapy for Gaucher's disease.

Authors:  R O Brady; N W Barton
Journal:  Lipids       Date:  1996-03       Impact factor: 1.880

Review 4.  Gaucher disease as a paradigm of current issues regarding single gene mutations of humans.

Authors:  E Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

Review 5.  Modifying exogenous glucocerebrosidase for effective replacement therapy in Gaucher disease.

Authors:  R O Brady; G J Murray; N W Barton
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

Review 6.  Enzyme replacement therapy of Fabry disease.

Authors:  Joe T R Clarke; R Mark Iwanochko
Journal:  Mol Neurobiol       Date:  2005-08       Impact factor: 5.590

7.  Enzyme replacement therapy for murine mucopolysaccharidosis type VII.

Authors:  M S Sands; C Vogler; J W Kyle; J H Grubb; B Levy; N Galvin; W S Sly; E H Birkenmeier
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

Review 8.  Enzyme replacement and enhancement therapies for lysosomal diseases.

Authors:  R J Desnick
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

9.  Failure of alglucerase infused into Gaucher disease patients to localize in marrow macrophages.

Authors:  E Beutler; W Kuhl; L M Vaughan
Journal:  Mol Med       Date:  1995-03       Impact factor: 6.354

10.  Feasibility of gene therapy in Gaucher disease using an adeno-associated virus vector.

Authors:  Young Bin Hong; Eun Young Kim; Han-Wook Yoo; Sung-Chul Jung
Journal:  J Hum Genet       Date:  2004-09-14       Impact factor: 3.172
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.